Morning Market Movers
September 15, 2014 at 09:42 AM EDT
Avanir Pharmaceuticals (NASDAQ: AVNR) shares jumped 47.48% to $9.94 after the company reported positive Phase II trial results for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|